IDEXX Laboratories Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
Aug 22

DJ IDEXX Laboratories Inc. Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of IDEXX Laboratories Inc. $(IDXX)$ slipped 1.06% to $633.05 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.40% to 6,370.17 and Dow Jones Industrial Average falling 0.34% to 44,785.50.

IDEXX Laboratories Inc. closed 8.00% below its 52-week high of $688.12, which the company reached on August 4th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 0.05% to $178.93, Medtronic PLC $(MDT)$ fell 2.27% to $91.10, and Boston Scientific Corp. $(BSX)$ fell 0.79% to $105.21.

Trading volume (252,938) remained 360,900 below its 50-day average volume of 613,838.

Data source: Dow Jones Market Data, FactSet. Data compiled August 21, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

August 21, 2025 16:49 ET (20:49 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10